| Ependymal Tumor studied in …STUDIED_INderived151 of 151show fewer |
|---|
| → studied in | NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07031765Phase 1 · active not recruiting Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03251989completed Rare CNS Tumors Outcomes &Risk · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06804655Phase 2 · recruiting Pharmacoscopy for Patients With Refractory Primary Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639607Phase 1/Phase 2 · suspended PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061626Phase 1 · recruiting Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07390539Phase 1 · recruiting B7-H3.CD28Z.CART in CNS Neoplasms · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04374305Phase 2 · recruiting Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173950Phase 2 · terminated Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03389802Phase 1 · completed Phase I Study of APX005M in Pediatric Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161519Phase 1/Phase 2 · recruiting PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05057702NA · recruiting Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03900689completed Social Determinants of Health in Glioblastoma Population · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04099797Phase 1 · recruiting C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04743661Phase 2 · active not recruiting 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07703605not yet recruiting AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02359565Phase 1 · active not recruiting Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05278208Phase 1/Phase 2 · recruiting Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07713745Phase 2 · not yet recruiting Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2) · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707947Phase 2 · not yet recruiting Selumetinib for NF2-Related Schwannomatosis · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05835687Phase 1 · active not recruiting Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03194906Phase 2 · completed Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00840047Phase 2 · active not recruiting Methionine PET/CT Studies In Patients With Cancer · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06193759Phase 1 · recruiting Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04732065Phase 1 · recruiting ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607692Phase 1/Phase 2 · recruiting Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03033992NA · active not recruiting Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04903080Phase 1 · active not recruiting HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04978727Phase 1 · active not recruiting A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07424092Phase 2 · recruiting Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03750513Phase 1 · recruiting LET Optimized IMPT in Treating Pediatric Patients With Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07589361not yet recruiting Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01096368Phase 3 · completed Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934630terminated Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185038Phase 1 · recruiting Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04661384Phase 1 · active not recruiting Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03152318Phase 1 · active not recruiting A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02125786Phase 2 · active not recruiting A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01795313Phase 1 · terminated Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05106296Phase 1 · recruiting Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04049669Phase 2 · active not recruiting Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06466798Phase 1 · withdrawn Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541082Phase 1 · recruiting Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03500991Phase 1 · active not recruiting HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03638167Phase 1 · completed EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05259605recruiting Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02238899completed Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06521567Phase 1/Phase 2 · active not recruiting A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02162732NA · completed Molecular-Guided Therapy for Childhood Cancer · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01165632early Phase 1 · completed Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01295944Phase 2 · completed Carboplatin and Bevacizumab for Recurrent Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06038760terminated Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO) · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03128047Phase 1 · completed HUMC 1612: Optune NovoTTF-200A System · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01288235Phase 2 · completed Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186509Phase 1 · completed Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03095248Phase 2 · terminated Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06779487recruiting Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03572530Phase 1 · completed Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06323408not yet recruiting Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02722512Phase 1 · terminated Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220035Phase 2 · completed Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233204Phase 2 · completed Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01247922Phase 2 · terminated Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04648462recruiting Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101905Phase 1 · completed Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04521946Phase 1 · withdrawn Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03990597Phase 1 · withdrawn StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06499636not yet recruiting In Vitro Models From Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06485908Phase 1/Phase 2 · not yet recruiting Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434262Phase 1 · completed SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02155920Phase 2 · completed Everolimus for Children With Recurrent or Progressive Ependymoma · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043391Phase 1 · completed Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206021Phase 1 · completed COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04408092early Phase 1 · completed Study of the Effect of GM-CSF on Macrophages in Ependymoma · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019578Phase 1 · completed Stereotactic Radiosurgery in Treating Patients With Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00634231Phase 1 · completed A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01721577Phase 1/Phase 2 · terminated Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860376completed Ex Vivo Drug Sensitivity Testing and Mutation Profiling · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730349Phase 1/Phase 2 · terminated A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05672043recruiting Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03727841Phase 2 · terminated Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02013297NA · completed Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics) · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003479Phase 2 · terminated Antineoplaston Therapy in Treating Patients With Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387020Phase 1 · completed Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01125046Phase 2 · completed Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01024907Phase 1/Phase 2 · completed Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02271711Phase 1 · completed Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502708Phase 1 · completed Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01331135Phase 1 · completed Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01478321Phase 2 · terminated Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684071Phase 2 · terminated Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01117155withdrawn A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00994071Phase 1 · completed A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251913terminated A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes · condition mapped ALIAS · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689336Phase 2 · withdrawn Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00749723Phase 2/Phase 3 · completed Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children · condition mapped ALIAS · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01836549Phase 2 · terminated Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919750completed Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234805NA · terminated Yoga Therapy in Treating Patients With Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234740Phase 1 · completed Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01171469Phase 1 · completed Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381797Phase 2 · completed Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194452NA · withdrawn Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01996527early Phase 1 · terminated 3T MRI Biomarkers of Glioma Treatment Response · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02967380NA · terminated Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02175745NA · terminated 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02976441early Phase 1 · withdrawn Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01407744completed Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326664Phase 1 · completed AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498783Phase 1 · completed Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119599Phase 1 · completed RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01462695Phase 2 · completed Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01082926Phase 1 · completed Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088035Phase 2 · terminated Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01131234Phase 1 · completed Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946335Phase 1 · completed ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095940Phase 1/Phase 2 · completed Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492089Phase 2 · completed Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052780Phase 1 · completed Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063973Phase 1 · completed Cilengitide in Treating Children With Refractory Primary Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100880Phase 1 · completed Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012181Phase 1 · completed Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00994500Phase 1 · completed Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004078Phase 2 · completed Irinotecan in Treating Children With Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01095094Phase 2 · terminated Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077454Phase 1 · completed Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091182Phase 2 · completed Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101270Phase 1 · completed Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas · condition mapped CURATED_BROADER · 151 trials mapped (50 active) | — | — | Childhood Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076530Phase 1 · completed Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030498Phase 1 · completed Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053963Phase 1 · completed FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00110032Phase 1 · terminated Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00363272Phase 1 · completed Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Childhood Infratentorial Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00430079NA · terminated Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Adult Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00517959Phase 3 · unknown SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors · condition mapped PROBABILISTIC · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520936Phase 2 · completed A Study of Pemetrexed in Children With Recurrent Cancer · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243490Phase 2 · withdrawn Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active) | — | — | Anaplastic Ependymoma | 1 | Observed | clinicaltrials | graph → |